| Literature DB >> 29883384 |
Eduardo De Carli1, Gisele Cristina Dias2, Juliana Massami Morimoto3, Dirce Maria Lobo Marchioni4, Célia Colli5.
Abstract
Predictive iron bioavailability (FeBio) methods aimed at evaluating the association between diet and body iron have been proposed, but few studies explored their validity and practical usefulness in epidemiological studies. In this cross-sectional study involving 127 women (18⁻42 years) with presumably steady-state body iron balance, correlations were checked among various FeBio estimates (probabilistic approach and meal-based and diet-based algorithms) and serum ferritin (SF) concentrations. Iron deficiency was defined as SF < 15 &micro;g/L. Pearson correlation, Friedman test, and linear regression were employed. Iron intake and prevalence of iron deficiency were 10.9 mg/day and 12.6%. Algorithm estimates were strongly correlated (0.69&le; r &ge;0.85; p < 0.001), although diet-based models (8.5⁻8.9%) diverged from meal-based models (11.6⁻12.8%; p < 0.001). Still, all algorithms underestimated the probabilistic approach (17.2%). No significant association was found between SF and FeBio from Monsen (1978), Reddy (2000), and Armah (2013) algorithms. Nevertheless, there was a 30⁻37% difference in SF concentrations between women stratified at extreme tertiles of FeBio from Hallberg and Hulth&eacute;n (2000) and Collings&rsquo; (2013) models. The results demonstrate discordance of FeBio from probabilistic approach and algorithm methods while suggesting two models with best performances to rank individuals according to their bioavailable iron intakes.Entities:
Keywords: algorithm; iron status; probabilistic approach
Mesh:
Substances:
Year: 2018 PMID: 29883384 PMCID: PMC5986529 DOI: 10.3390/nu10050650
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Summary characteristics of the five tested iron bioavailability algorithms.
| Algorithm Model | Calculus Basis | Dietary Factors Adjusting Non-Heme Iron Absorption | Dietary Factors Adjusting Heme Iron Absorption | Adjustment Made for Individual’s Body Iron Status |
|---|---|---|---|---|
| Monsen et al. (1978) [ | Meals | Cooked animal tissues | None | Heme and nonheme iron absorption are corrected for the body iron stores of 0, 250, 500, and 1000 mg, using specific correction factors. |
| Hallberg and Hulthén (2000) [ | Meals | Raw animal tissues | Calcium | Heme and nonheme iron absorptions are corrected according to serum ferritin concentration, using two independent equations. |
| Reddy et al. (2000) [ | Meals | Cooked animal tissues | None | Nonheme iron absorption is corrected according to serum ferritin concentration, using an equation proposed by Cook [ |
| Armah et al. (2013) [ | Complete diets | Cooked animal tissues | None | Nonheme iron absorption is corrected according to serum ferritin concentration, using an equation incorporate in the same model of adjustments for dietary factors. Lacks a correction term for heme iron absorption. A fixed factor of 25% of heme iron absorption was assumed, as proposed by the Institute of Medicine [ |
| Collings et al. (2013) [ | Complete diets | Diets are categorized into 3 types: Self-selected (standard diet) With inhibitors (high calcium, low vitamin C, no meat) With enhancers (low calcium, high vitamin C, high meat) | None | Nonheme iron absorption is corrected according to serum ferritin concentration, using an equation incorporate in the same model of adjustments for dietary factors. Lacks a correction term for heme iron absorption. A fixed factor of 25% of heme iron absorption was assumed, as proposed by the Institute of Medicine [ |
Figure 1Study flow diagram.
General characterization of women at presumably steady-state body iron balance.
| Selected Characteristics | Overall Sample | Hormonal Contraceptives | |
|---|---|---|---|
| Non-users | Users | ||
| ( | ( | ( | |
|
| |||
| Age (years) | 27.4 (5.1) [18.0–42.0] | 27.8 (6.0) | 27.2 (4.3) |
| >30 year, n (%) | 34 (26.8) | 19 (36.5) | 15 (20.0) # |
| Body Mass Index (kg/m2) | 22.1 (2.4) [17.0–29.1] | 21.8 (2.4) | 22.2 (2.4) |
| >25 Kg/m2, n (%) | 14 (11.0) | 5 (9.6) | 9 (12.0) |
| Waist circumference (cm) | 75.4 (7.1) [60.5–99.3] | 75.9 (7.1) | 75.5 (7.1) |
| >80 cm, n (%) | 33 (26.0) | 15 (28.8) | 18 (24.0) |
| Self-declared skin color/race, n (%) | |||
| White | 95 (74.8) | 36 (69.2) | 59 (78.7) |
| Black or brown/mixed | 24 (18.9) | 11 (21.2) | 13 (17.3) |
| Yellow/Asian | 8 (6.3) | 5 (9.6) | 3 (4.0) |
| Socioeconomic level, n (%) * | |||
| Class A | 15 (12.0) | 6 (11.5) | 9 (12.3) |
| Class B | 86 (68.8) | 30 (57.7) | 56 (76.7) # |
| Classes C or D | 24 (19.2) | 16 (30.8) | 8 (11.0) # |
| Self-declared diet, n (%) | |||
| Omnivorous | 109 (85.8) | 43 (82.7) | 66 (88.0) |
| Vegetarians or meat restrictors | 18 (14.2) | 9 (17.3) | 9 (12.0) |
| Physical Activity Level, n (%) | |||
| Active | 62 (48.8) | 22 (42.3) | 40 (53.3) |
| Very active | 16 (12.6) | 7 (13.5) | 9 (12.0) |
| Insufficiently active | 49 (38.6) | 23 (44.2) | 26 (34.7) |
|
| |||
| Periods duration, n (%) | |||
| 2–3 days | 20 (15.7) | 6 (11.5) | 14 (18.7) |
| 4–5 days | 89 (70.1) | 37 (71.2) | 52 (69.3) |
| 6–7 days | 18 (14.2) | 9 (17.3) | 9 (12.0) |
| Menstrual flow intensity score, n (%) | |||
| Tertile 1 (≤13 units) | 44 (34.6) | 14 (26.9) | 30 (40.0) ## |
| Tertile 2 (14–21 units) | 39 (30.7) | 12 (23.1) | 27 (36.0) ## |
| Tertile 3 (≥22 units) | 44 (34.6) | 26 (50.0) | 18 (24.0) ## |
|
| |||
| Hemoglobin (g/dL) | 13.4 (0.8) [11.0–15.4] | 13.4 (0.9) | 13.4 (0.8) |
| <12 g/dL, n (%) | 4 (3.1) | 3 (5.8) | 1 (1.3) |
| Transferrin saturation (%) | 29.9 (11.4) [6.4–59.7] | 30.1 (12.8) | 29.8 (10.3) |
| <16%, n (%) | 14 (11.0) | 7 (13.5) | 7 (9.3) |
| Ferritin (µg/L) ** | 36.6 (31.4; 42.6) [4.0–198.0] | 31.0 (23.6; 40.7) | 41.0 (34.3; 49.0) |
| <15 µg/L, n (%) | 16 (12.6) | 11 (21.2) | 5 (6.7) # |
| Alfa1-Acid Glycoprotein (mg/dL) | 61.4 (18.9) [26.0–133.0] | 65.6 (16.4) | 71.9 (20.8) |
| ≥100 mg/dL, n (%) | 4 (3.1) | 2 (3.8) | 2 (2.7) |
| High-sensitive C-Reactive Protein (mg/L) | 1.1 (0.9; 1.3) [0.2–9.8] | 0.5 (0.4; 0.7) | 1.7 (1.4; 2.3) ## |
| ≥5 mg/L, n (%) | 15 (11.8) | 1 (1.9) | 14 (18.7) ## |
|
| |||
| Total energy (kcal/day) | 2032.5 (436.5) [958.0–3531.9] | 1984.6 (465.5) | 2065.7 (415.1) |
| Total iron (mg/day) | 10.9 (2.2) [6.1–19.5] | 10.3 (2.2) | 11.2 (2.2) # |
| Non-heme iron (mg/day) | 10.2 (2.2) [5.8–18.1] | 9.6 (2.1) | 10.5 (2.2) # |
| Fortification iron (mg/day) | 3.2 (1.2) [0.4–6.3] | 2.9 (1.3) | 3.4 (1.1) # |
| Heme iron (mg/day) | 0.7 (0.4) [0.0–2.1] | 0.7 (0.5) | 0.7 (0.4) |
| Animal tissues (g/day) 1 | 169.9 (76.8) [0.0–325.2] | 172.1 (79.6) | 168.4 (75.2) |
| Vitamin C (mg/day) | 129.0 (81.9) [20.5–434.1] | 121.1 (65.8) | 134.5 (91.5) |
| Calcium (mg/day) | 845.1 (285.8) [210.3–1872.1] | 844.6 (2851) | 845.5 (288.2) |
| Phytate (mg/day) 2 | 260.2 (84.1) [82.0–563.5] | 246.7 (77.7) | 269.5 (87.5) |
| Polyphenols (mg/day) 3 | 223.3 (82.7) [56.4–563.0] | 234.1 (94.1) | 215.8 (73.4) |
| Tea and coffee equivalents (cups/day) 4 | 0.3 (0.3; 0.4) [0.0–2.0] | 0.4 (0.3; 0.5) | 0.3 (0.2; 0.4) |
| Alcohol (g/day) | 1.1 (1.0; 1.3) [0.0–11.3] | 1.1 (0.9; 1.4) | 1.1 (1.0; 1.3) |
Values are mean (SD), geometric mean (95% CI) or absolute count (percentage). Ranges for continuous variables are listed in brackets. * Data missing for two participants. ** Inflammation-corrected SF values were transformed into natural logarithm before analysis. 1 Raw tissue. 2 Phytate phosphorous. 3 Tannic acid equivalents. 4 As proposed by Armah et al. (2013) [13]. #. ## Significant difference between hormonal contraceptive users and non-users according to t-Student’s test (continuous variables) or Chi-Squared, Likelihood Ratio or Fisher tests (categorical variables). # p < 0.05; ## p < 0.01.
Figure 2Predicted prevalence of inadequate iron intakes at different dietary iron bioavailabilities, according to the probabilistic approach proposed by Dainty et al. [14]. Values in boxes are prevalence of iron deficiency (serum ferritin < 15 µg/L). Mean dietary iron bioavailabilities of 16% and 19% were estimated for hormonal contraceptive users and non-users, respectively.
Dietary iron bioavailability (FeBio) estimates according to meal-based and diet-based algorithms.
| Algorithm Models | Absolute FeBio (mg/day) | Relative FeBio (%) |
|---|---|---|
| Monsen et al. (1978) [ | 1.26 (0.36) [0.45–2.44] a | 11.57 (2.21) [6.54–17.95] a |
| Hallberg and Hulthén (2000) [ | 1.30 (0.42) [0.44–2.88] a | 12.02 (3.34) [4.10–24.90] a |
| Reddy et al. (2000) [ | 1.38 (0.48) [0.40–3.41] a | 12.80 (3.87) [3.61–25.07] a |
| Armah et al. (2013) [ | 0.96 (0.21) [0.49–1.67] b | 8.91 (1.36) [5.62–13.33] b |
| Collings et al. (2013) [ | 0.92 (0.23) [0.49–1.84] b | 8.51 (1.04) [4.61–11.44] b |
n = 127. Values are mean (SD). Ranges are listed in brackets. Friedman’s test indicates significant differences between estimates of both absolute and relative iron bioavailability (p < 0.001). a, b Different subscribed letters in a same column indicate statistical difference between algorithm models, according to Dunn’s post hoc test.
Correlation coefficients and simple linear regression equations of the bivariate relationship between iron bioavailability estimates (mg/day).
| Algorithm Models | ||||
|---|---|---|---|---|
| Hallberg and Hulthén | r = 0.823 | |||
| Reddy et al. | r = 0.718 | r = 0.851 | ||
| Armah et al. | r = 0.850 | r = 0.836 | r = 0.749 | |
| Collings et al. | r = 0.793 | r = 0.764 | r = 0.694 | r = 0.809 |
n = 127. Pearson’s correlation test was used. All models had p < 0.001.
Figure 3Serum ferritin (µg/L) of women classified according to tertiles of bioavailable iron intake (mg/day). n = 127. Bars and whiskers indicate geometric mean and 95% confidence intervals, respectively. * p < 0.05, ** p < 0.01—in comparison to the first tertile, according to multiple linear regression adjusted for age, body mass index, skin color/race, physical activity level, hormonal contraceptives use and menstrual flow intensity level.